Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAMP3 | O60896 | 11/20 | 0.46 |
| ▸ | CALCR | P30988 | 11/20 | 0.46 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.44 |
| ▸ | GRB2 | P62993 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.44 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12339085 | 1.00 | RAMP3 (0.46) | RAMP3CALCRIL23RGRB2OPRM1 | |
| SCHEMBL14452355 | 0.92 | GRB2 (0.45) | RAMP3CALCRGRB2OPRM1OPRK1 | |
| SCHEMBL13084700 | 0.91 | RAMP3 (0.47) | RAMP3CALCRIL23RGRB2OPRM1 | |
| SCHEMBL13084645 | 0.91 | RAMP3 (0.47) | RAMP3CALCRIL23RGRB2OPRM1 | |
| SCHEMBL12314876 | 0.91 | RAMP3 (0.47) | RAMP3CALCRIL23RGRB2OPRM1 | |
| SCHEMBL12314880 | 0.91 | RAMP3 (0.47) | RAMP3CALCRIL23RGRB2OPRM1 | |
| SCHEMBL16351202 | 0.90 | OPRM1 (0.49) | RAMP3CALCRGRB2OPRM1OPRK1 | |
| SCHEMBL16330316 | 0.89 | RAMP3 (0.45) | RAMP3CALCRIL23RGRB2OPRM1 | |
| SCHEMBL16340730 | 0.87 | RAMP3 (0.50) | RAMP3CALCRIL23R | |
| SCHEMBL13084631 | 0.86 | GRB2 (0.50) | RAMP3CALCRGRB2OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8263739-B2 | also targeting tumor cells that express vascular endothelial growth factor neuropilin-1 receptor; radiotherapy; radiopharmaceuticals; treating angiogenesis | BRACCO SUISSE SA (CH) | 2012-09-11 | — | — | US | disclosed |